Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Refac Optical Group, primarily known through its subsidiary U.S. Vision, was a major provider of optical products and services in the United States. Historically, the company operated as Refac International, a prominent technology transfer and licensing firm that played a pivotal role in the commercialization of the Palmaz-Schatz balloon-expandable stent, a landmark medical device in interventional cardiology. Following a strategic shift in the early 2000s, the company focused on the retail optical market, operating vision centers within major department stores and host retailers. While the parent entity was acquired and restructured, its legacy remains tied to both significant medical device licensing and large-scale healthcare retail operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Refac.